期刊文献+

高甘油三酯血症患者动脉僵硬度与超敏C反应蛋白的相关性研究 被引量:8

The relationship between arterial stiffness and serum levels of high-sensitivity C-reactive protein in patients with hypertriglyceridemia
下载PDF
导出
摘要 目的探讨高甘油三酯血症患者动脉僵硬度与超敏C反应蛋白(hsCRP)的关系。方法以脉搏波速度(PWV)水平作为动脉僵硬度的评价手段。112名高甘油三酯血症患者根据动脉硬化的程度分为低PWV组和高PWV组,分别测定肱踝脉搏波传导速度(ba-PWV)和hsCRP,并收集相关临床资料。结果高PWV组log hsCRP水平显著高于低PWV组(P<0.05)。偏相关分析显示在校正年龄、性别、吸烟史、合并用药情况、冠心病、高血压、血脂谱、空腹血糖、胰岛素抵抗指数后ba-PWV和log hsCRP正相关(r=0.261,P=0.039)。多元回归分析显示年龄(P<0.01)、收缩压(P<0.05)及log hsCRP(P<0.05)与ba-PWV相关。结论高甘油三酯血症患者中hsCRP与ba-PWV水平相关,提示动脉僵硬度可能与全身的炎症状态相关。 Objective To investigate the relationship between pulse wave velocity (PWV) and high-sensitivity C-reactive protein (hsCRP) in patients with hypertriglyceridemia. Methods 112 patients with hypertriglyceridemia were divided into low PWV group (n =56) and high PWV group (n =56), brachial to ankle PWV (ba-PWV) and serum levels of hsCRP were measured respectively. The related clinical data were collected in all patients. Results The serum levels of log hsCRP were higher significantly in high PWV group compared with low PWV group ( P 〈 0.05 ). Mter adjusting for age, sex, smoking, drugs, coronary heart disease, hypertension, lipid profile, fasting blood glucose (FBG) and insulin resistance index ( HOMA-IR), ba-PWV was positively correlated with log hsCRP ( r = 0.261, P = 0. 039 ). Multiple stepwise regression showed that age ( P 〈 0. 01 ), systolic blood pressure ( P 〈 0. 05 ) and log hsCRP ( P 〈 0.05 ) were correlated with ba-PWV. Conclusion Age, systolic blood pressure and hsCRP are independent predictors to ba-PWV in patients with hypertriglyceridemia. Arterial stiffness is correlated with the systemic inflammatory state.
出处 《山东医药》 CAS 北大核心 2009年第4期7-9,共3页 Shandong Medical Journal
基金 国家自然科学基金面上项目(30770873) 中华医学会临床医学科研专项基金(07060590067)
关键词 高甘油三酯血症 动脉僵硬度 C反应蛋白质 hypertriglyceridemia arterial stiffness C-reactive protein
  • 相关文献

参考文献9

  • 1van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study [ J ]. Stroke, 2001,32(2) :454-460.
  • 2Nagano M, Nakamura M, Sato K, et al. Association between serum C-reactive protein levels and pulse wave velocity : a population-based cross-sectional study in a general population [ J ]. Athereselerosis, 2005,180 ( 1 ) : 189-195.
  • 3Kim JS, Kang TS, Kim JB, et al. Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients [ J ]. Atherosclerosis, 2007,192 (2) :401-406.
  • 4Oliveira AC, Oliveira AM, Adan LF, et al. C-reactive protein and metabolic syndrome in youth: a strong relationship [ J ] ? Obesity ( Silver Spring), 2008,16(5 ) : 1094-1098.
  • 5London GM, Marchais SJ, Guerin AP, et al. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients [ J ]. Kidney Int Suppl, 2003, (84) : S88-93.
  • 6Scuteri A, Najjar SS, Muller DC, et at. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness [J]. J Am Coil Cardiol, 2004,43(8) :1388-1395.
  • 7Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle [ J]. Circulation, 2003,107 ( 13 ) : 1783-1790.
  • 8Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial ceils [ J ]. Circulation, 2000, 102 (18) :2165-2168.
  • 9Pasceri V, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant pretein-1 induction in human endothelial cells by anti-atherosclerosis drugs [ J ]. Circulation, 2001,103(21 ) :2531-2534.

同被引文献75

  • 1朱壮春,袁强,郝东生.冠心病患者血清超敏C-反应蛋白的表达和意义[J].中国综合临床,2005,21(10):880-881. 被引量:4
  • 2赵水平.他汀类抗动脉粥样硬化的非降脂作用[J].中华老年多器官疾病杂志,2005,4(2):90-92. 被引量:12
  • 3刘红英,刘丽珍,黎苗,欧毛德.超敏C反应蛋白与不同类型冠心病关系的Meta分析[J].中国全科医学,2006,9(6):462-464. 被引量:12
  • 4Boucher BJ,Timms PM,Hitman GA.Association between fasting glucose and C-reactive protein in middle-aged subjects[J].Diabet Med,2005,22(4):508-509.
  • 5Ridker PM,Rafai N,Rose L,et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].N Engl J Med,2002,347(20):1557-1565.
  • 6Ridker PM,Rafai N,Cook NR,et al.Non-HDL cholesterol,Apo lipoprotein A-1 and B100 standard lipid measures,lipid ratio and CRP at risk factors for cardiovascular disease in women[J].JAMA,2005,294(3):326-333.
  • 7Rideker PM,Danielson E,Fonsela F,et al.Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein[J].N Engl J Med,2008,359(21):2195-2207.
  • 8Ridker PM.High-sensitivity C-reactive protein:potential adjunct for global risk assessment in the primary prevention of cardiovascular disease[J].Circulation,2001,103(13):1813-1818.
  • 9European Society of Hypertension-European Society of Cardiology Guidelines Committee.2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003,21(6):1011-1053.
  • 10Pinto A,Tuttolomondo A,Di RaimondoD,et al.Cerebrovascular risk factors and clinical classification of strokes[J].Semin Vasc Med,2004,4(3):287-303.

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部